ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements with these filters
Nectar Lifesciences Limited has announced the appointment of Dr. Gunmala Suri as a Director. Additionally, three other directors have been re-appointed to the Board.
Nectar Lifesciences filed proceedings of its 31st AGM held September 18, 2026. Resolutions covered adoption of FY26 financials and director re-appointments.
Nectar Lifesciences Ltd. has released its Annual Report for FY 2025-26. The 31st Annual General Meeting is scheduled for September 18, 2026, via video conferencing.
Nectar Lifesciences Limited announced a change in its corporate office address, moving to Godrej Eternia in Chandigarh effective September 15, 2026.
Nectar Lifesciences Limited has appointed Dr. Gunmala Suri as an Additional Director, effective August 15, 2026.
Nectar Lifesciences Ltd. has announced that its 31st Annual General Meeting will be held on September 18, 2026. The book closure period is set from September 12, 2026, to September 18, 2026.
Nectar Lifesciences Ltd reported revenue from operations of ₹0.4 Cr and a net loss of ₹15.4 Cr for Q1 FY27.
Nectar Lifesciences Ltd. has scheduled a board meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Dr. Surulichamy Senthilkumar has resigned as a Non-Executive Non-Independent Director of Nectar Lifesciences Ltd., effective August 06, 2026, due to personal reasons.
Nectar Lifesciences sold its non-core unit, Narbada Industries, including land leasehold rights and machinery, to Shree Balaji Cold Chain & Storage Services for ₹11.22 Crore.
Nectar Lifesciences extended the expected completion date for the slump sale of its Empty Hard Gelatin Capsule business to Capnest Health Care to December 31, 2026.
Nectar LifeSciences Ltd filed its shareholding pattern as per Regulation 31(1)(b), detailing promoter and public holdings as of June 30, 2026. No monetary transaction disclosed.
Nectar Lifesciences shifted its registered office within Dera Bassi, Punjab. This administrative change does not affect the company's operations or statutory registrations.